Literature DB >> 19410142

Intra and interfraction mediastinal nodal region motion: implications for internal target volume expansions.

Jonathan G Thomas1, Rojano Kashani, James M Balter, Daniel Tatro, Feng-Ming Kong, Charlie C Pan.   

Abstract

The purpose of this study was to determine the intra and interfraction motion of mediastinal lymph node regions. Ten patients with nonsmall-cell lung cancer underwent controlled inhale and exhale computed tomography (CT) scans during two sessions (40 total datasets) and mediastinal nodal stations 1-8 were outlined. Corresponding CT scans from different sessions were registered to remove setup error and, in this reference frame, the centroid of each nodal station was compared for right-left (RL), anterior-posterior (AP), and superior-inferior (SI) displacement. In addition, an anisotropic volume expansion encompassing the change of the nodal region margins in all directions was used. Intrafraction displacement was determined by comparing same session inhale-exhale scans. Interfraction reproducibility of nodal regions was determined by comparing the same respiratory phase scans between two sessions. Intrafraction displacement of centroid varied between nodal stations. All nodal regions moved posteriorly and superiorly with exhalation, and inferior nodal stations showed the most motion. Based on anisotropic expansion, nodal regions expanded mostly in the RL direction from inhale to exhale. The interpatient variations in intrafraction displacement were large compared with the displacements themselves. Moreover, there was substantial interfractional displacement ( approximately 5 mm). Mediastinal lymph node regions clearly move during breathing. In addition, deformation of nodal regions between inhale and exhale occurs. The degree of motion and deformation varies by station and by individual. This study indicates the potential advantage of characterizing individualized nodal region motion to safely maximize conformality of mediastinal nodal targets.

Entities:  

Mesh:

Year:  2008        PMID: 19410142      PMCID: PMC2714530          DOI: 10.1016/j.meddos.2008.07.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  22 in total

1.  Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART).

Authors:  Peter Jenkins; Karen D'Amico; Kim Benstead; Sean Elyan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

2.  The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.

Authors:  Bahman Emami; Nena Mirkovic; Charles Scott; Roger Byhardt; Mary V Graham; E James Andras; Madhu John; Arnold Herskovic; Raul Urtasun; Sucha O Asbell; Carlos A Perez; James Cox
Journal:  Lung Cancer       Date:  2003-08       Impact factor: 5.705

3.  Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.

Authors:  Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Scott A Merrick; Dorota Gabrys; Ennapadam S Venkatraman; Chandra M Burman; Steven A Leibel; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

4.  Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.

Authors:  Suresh Senan; Sjaak Burgers; Michael J Samson; Rob J van Klaveren; Swie Swat Oei; John van Sörnsen de Koste; Peter W J Voet; Frank J Lagerwaard; Jan Maarten van Haarst; Joachim G J V Aerts; Jan P van Meerbeeck
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-15       Impact factor: 7.038

5.  The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy.

Authors:  L A Dawson; K K Brock; S Kazanjian; D Fitch; C J McGinn; T S Lawrence; R K Ten Haken; J Balter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-12-01       Impact factor: 7.038

6.  What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer?

Authors:  John R van Sörnsen de Koste; Frank J Lagerwaard; Margriet R J Nijssen-Visser; Regine Schuchhard-Schipper; Hans Joosten; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

7.  Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.

Authors:  Yvette Seppenwoolde; Joos V Lebesque; Katrien de Jaeger; José S A Belderbos; Liesbeth J Boersma; Cees Schilstra; George T Henning; James A Hayman; Mary K Martel; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

8.  Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.

Authors:  Tiziana Rancati; Giovanni Luca Ceresoli; Giovanna Gagliardi; Stefano Schipani; Giovanni Mauro Cattaneo
Journal:  Radiother Oncol       Date:  2003-06       Impact factor: 6.280

9.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy.

Authors:  Yvette Seppenwoolde; Hiroki Shirato; Kei Kitamura; Shinichi Shimizu; Marcel van Herk; Joos V Lebesque; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

10.  Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.

Authors:  Kayoko Tsujino; Saeko Hirota; Masahiro Endo; Kayoko Obayashi; Yoshikazu Kotani; Miyako Satouchi; Tetsuji Kado; Yoshiki Takada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

View more
  6 in total

1.  Tumor, lymph node, and lymph node-to-tumor displacements over a radiotherapy series: analysis of interfraction and intrafraction variations using active breathing control (ABC) in lung cancer.

Authors:  Elisabeth Weiss; Scott P Robertson; Nitai Mukhopadhyay; Geoffrey D Hugo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-22       Impact factor: 7.038

2.  Adaptive radiation for lung cancer.

Authors:  Daniel R Gomez; Joe Y Chang
Journal:  J Oncol       Date:  2010-08-04       Impact factor: 4.375

3.  Interfraction displacement of primary tumor and involved lymph nodes relative to anatomic landmarks in image guided radiation therapy of locally advanced lung cancer.

Authors:  Nuzhat Jan; Salim Balik; Geoffrey D Hugo; Nitai Mukhopadhyay; Elisabeth Weiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-11-13       Impact factor: 7.038

4.  (18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.

Authors:  Ang Gao; Shijiang Wang; Zheng Fu; Xindong Sun; Jinming Yu; Xue Meng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Respiratory motion variability of primary tumors and lymph nodes during radiotherapy of locally advanced non-small-cell lung cancers.

Authors:  Nuzhat Jan; Geoffrey D Hugo; Nitai Mukhopadhyay; Elisabeth Weiss
Journal:  Radiat Oncol       Date:  2015-06-14       Impact factor: 3.481

6.  Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective Study.

Authors:  Julian Jacob; Steve Heymann; Isabelle Borget; Isabelle Dumas; Elyes Riahi; Pierre Maroun; Patrick Ezra; Elena Roberti; Sofia Rivera; Eric Deutsch; Céline Bourgier
Journal:  Front Oncol       Date:  2015-09-16       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.